Has experience in Biotechnology, focusing on Biotechnology in Human and Animal Health (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The cancer immunotherapies have shown promising results compared to the conventional therapies, such as the adoptive therapy of T lymphocytes expressing chimeric antigen receptors (CAR) in the treatment of hematological malignancies. However, the therapeutic efficacy of CAR-T lymphocytes against solid tumors, which represent the majority of tumors, is still insufficient. One of the reason…
The adoptive therapy of T lymphocytes expressing chimeric antigen receptors (CAR) has demonstrated impressive results in the treatment of some hematological malignancies. However, the therapeutic efficacy of CAR-T cells is still low or non-existent against solid tumors, which make up the vast majority of neoplasms. One of the main reasons for this failure is the presence of ligands and im…
The therapies based on synthetic biology to modify T cell to express chimeric antigen receptor (CAR) have emerge as a revolutionary approach to treat hematological malignancies, and now are established as a treatment for relapse and/or refractory patients. However, the therapeutic efficacy of CAR-T cells is still low against solid tumors. The treatment of solid tumors with CAR-T cells is …
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID